Figure 1.
Experimental strategy to study the impact of controlling obesity on melanoma progression in mice. (A) Impact of controlling diet‐induced obesity on melanoma progression in HFD C57BL/6J or NOD/SCID mice. (B) Effect of (a) pre‐treatment, or (b) post treatment with orlistat, at antiobesity dose (10 mg/kg, oral), on melanoma progression in ND C57BL/6J mice.